Renin–angiotensin system blocker discontinuation and adverse outcomes in chronic kidney disease
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Renin–angiotensin system blocker discontinuation and adverse outcomes in chronic kidney disease
Authors
Keywords
-
Journal
NEPHROLOGY DIALYSIS TRANSPLANTATION
Volume -, Issue -, Pages -
Publisher
Oxford University Press (OUP)
Online
2020-11-05
DOI
10.1093/ndt/gfaa300
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Longer Predialysis ACEi/ARB Utilization Is Associated With Reduced Postdialysis Mortality
- (2020) Elvira O. Gosmanova et al. AMERICAN JOURNAL OF MEDICINE
- Association Between Renin-Angiotensin System Blockade Discontinuation and All-Cause Mortality Among Persons With Low Estimated Glomerular Filtration Rate
- (2020) Yao Qiao et al. JAMA Internal Medicine
- Stopping RAS Inhibitors to Minimize Acute Kidney Injury
- (2019) Charles Tomson et al. Clinical Journal of the American Society of Nephrology
- Trends in Angiotensin-Converting Enzyme Inhibitor and Angiotensin II Receptor Blocker Use among Those with Impaired Kidney Function in the United States
- (2019) Daniel P. Murphy et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- Discontinuation of Angiotensin Converting Enzyme Inhibitors and Angiotensin Receptor Blockers in Chronic Kidney Disease
- (2019) Yao Qiao et al. MAYO CLINIC PROCEEDINGS
- Facility-Level Variations in Kidney Disease Care among Veterans with Diabetes and CKD
- (2018) Sankar D. Navaneethan et al. Clinical Journal of the American Society of Nephrology
- Renin–angiotensin system inhibition in advanced chronic kidney disease
- (2018) Roopa Shah et al. CURRENT OPINION IN NEPHROLOGY AND HYPERTENSION
- Association of Angiotensin-Converting Enzyme Inhibitor or Angiotensin Receptor Blocker Use With Outcomes After Acute Kidney Injury
- (2018) Sandeep Brar et al. JAMA Internal Medicine
- What are the risks and benefits of temporarily discontinuing medications to prevent acute kidney injury? A systematic review and meta-analysis
- (2017) Penny Whiting et al. BMJ Open
- Prescription of renin–angiotensin system blockers and risk of acute kidney injury: a population-based cohort study
- (2016) Kathryn E Mansfield et al. BMJ Open
- Validity of Diagnostic Codes for Acute Stroke in Administrative Databases: A Systematic Review
- (2015) Natalie McCormick et al. PLoS One
- A New Equation to Estimate Glomerular Filtration Rate
- (2013) Andrew S. Levey et al. ANNALS OF INTERNAL MEDICINE
- Major Barriers against Renin–Angiotensin–Aldosterone System Blocker Use in Chronic Kidney Disease Stages 3–5 in Clinical Practice: A Safety Concern?
- (2012) Tolga Yildirim et al. RENAL FAILURE
- The impact of stopping inhibitors of the renin-angiotensin system in patients with advanced chronic kidney disease
- (2009) A. K. Ahmed et al. NEPHROLOGY DIALYSIS TRANSPLANTATION
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started